Atlas Venture Life Science Advisors, LLC Q2 2023 Filing
Filed August 11, 2023
Portfolio Value
$803.6B
Holdings
15
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (15 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IRONDisc Medicine, Inc. | 3,461,784 | $153.7B | 19.13% | |
| 2 | KYMRKymera Therapeutics, Inc. | 5,858,262 | $134.7B | 16.76% | |
| 3 | DYNDyne Therapeutics, Inc. | 9,885,449 | $111.2B | 13.84% | |
| 4 | DAWNDay One Biopharmaceuticals, Inc. | 7,608,394 | $90.8B | 11.31% | |
| 5 | VIGLVigil Neuroscience, Inc. | 5,836,874 | $54.9B | 6.83% | |
| 6 | THRDThird Harmonic Bio, Inc. | 10,907,859 | $52.5B | 6.53% | |
| 7 | REPLReplimune Group, Inc. | 2,098,300 | $48.7B | 6.06% | |
| 8 | GBIOGBXGeneration Bio, Co. | 8,279,484 | $45.5B | 5.67% | |
| 9 | AVTEAerovate Therapeutics, Inc. | 2,039,249 | $35.0B | 4.35% | |
| 10 | —Ikena Oncology, Inc. | 5,018,178 | $32.9B | 4.10% | |
| 11 | AKROAkero Therapeutics, Inc. | 594,251 | $27.7B | 3.45% | |
| 12 | XLOXilio Therapeutics, Inc. | 2,759,344 | $7.2B | 0.90% | |
| 13 | —AvroBio, Inc. | 4,541,381 | $4.3B | 0.54% | |
| 14 | —Magenta Therapeutics, Inc. | 3,791,698 | $2.9B | 0.36% | |
| 15 | SPROSpero Therapeutics, Inc. | 1,013,438 | $1.5B | 0.18% |